Eculizumab cessation in atypical hemolytic uremic syndrome

SA Merrill, ZD Brittingham, X Yuan… - Blood, The Journal …, 2017 - ashpublications.org
Atypical hemolytic uremic syndrome (aHUS) is a complementmediated thrombotic
microangiopathy (TMA) characterized by mechanical hemolysis, renal impairment …
被引用次数：80 相关文章

[引用][C] Eculizumab cessation in atypical hemolytic uremic syndrome

SA Merrill, ZD Brittingham, X Yuan, AR Moliterno… - Blood, 2017 - jhu.pure.elsevier.com
Eculizumab cessation in atypical hemolytic uremic syndrome — Johns Hopkins University Skip to
main navigation Skip to search Skip to main content Johns Hopkins University Home Johns …

[引用][C] Eculizumab cessation in atypical hemolytic uremic syndrome

SA Merrill, ZD Brittingham, X Yuan, AR Moliterno… - Blood, 2017 - cir.nii.ac.jp
Eculizumab cessation in atypical hemolytic uremic syndrome | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の博士 …

Eculizumab cessation in atypical hemolytic uremic syndrome.

SA Merrill, ZD Brittingham, X Yuan, AR Moliterno… - Blood, 2017 - europepmc.org
Atypical hemolytic uremic syndrome (aHUS) is a complement-mediated thrombotic
microangiopathy (TMA) characterized by mechanical hemolysis, renal impairment …
[HTML] nih.gov

[HTML][HTML] Eculizumab cessation in atypical hemolytic uremic syndrome

SA Merrill, ZD Brittingham, X Yuan, AR Moliterno… - Blood, 2017 - ncbi.nlm.nih.gov
Eculizumab cessation in atypical hemolytic uremic syndrome - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

[引用][C] Eculizumab cessation in atypical hemolytic uremic syndrome

SA Merrill, ZD Brittingham, X Yuan, AR Moliterno… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Eculizumab cessation in atypical hemolytic uremic syndrome Eculizumab cessation in
atypical hemolytic uremic syndrome Blood. 2017 Jul 20;130(3):368-372. doi: 10.1182/blood-2017-02-770214 …

[引用][C] Eculizumab cessation in atypical hemolytic uremic syndrome

SA Merrill, ZD Brittingham, X Yuan, AR Moliterno… - Blood, 2017 - pure.johnshopkins.edu
Eculizumab cessation in atypical hemolytic uremic syndrome — Johns Hopkins University Skip to
main navigation Skip to search Skip to main content Johns Hopkins University Home Johns …

Eculizumab cessation in atypical hemolytic uremic syndrome.

SA Merrill, ZD Brittingham, X Yuan, AR Moliterno… - Blood, 2017 - europepmc.org
Atypical hemolytic uremic syndrome (aHUS) is a complement-mediated thrombotic
microangiopathy (TMA) characterized by mechanical hemolysis, renal impairment …